Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 757 (108th)

Drug Company Gift Disclosure Act

referredUnited States· United States Congress· EN

Introduced

13 February 2003

Last action

26 February 2003 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. DeFazio, Peter A. [D-OR-4], Sen. Brown, Sherrod [D-OH], Rep. Stark, Fortney Pete [D-CA-13], Rep. Crowley, Joseph [D-NY-14], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Lantos, Tom [D-CA-12], Rep. Berry, Marion [D-AR-1], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Davis, Danny K. [D-IL-7], Rep. Miller, George [D-CA-11], Rep. Michaud, Michael H. [D-ME-2], Rep. Wynn, Albert Russell [D-MD-4], Rep. McDermott, Jim [D-WA-7], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Frost, Martin [D-TX-24], Rep. Doggett, Lloyd [D-TX-37], Sen. Sanders, Bernard [I-VT], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Lipinski, William O. [D-IL-3], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Bishop, Timothy H. [D-NY-1], Rep. Lee, Barbara [D-CA-12], Rep. Israel, Steve [D-NY-3], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Kucinich, Dennis J. [D-OH-10], Rep. Gutierrez, Luis V. [D-IL-4], Rep. Emanuel, Rahm [D-IL-5], Rep. Thompson, Bennie G. [D-MS-2]

Subjects

Discovery layer

Source updated

18 August 2025

Official sourceDownload fileView documentsShare

Summary

Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 February 2003

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 13 February 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 13 February 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 26 February 2003

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 13 February 2003

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 13 February 2003

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 13 February 2003

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.